Literature DB >> 33000679

Effect of Different Intensities of Transcranial Direct Current Stimulation on Postural Response to External Perturbation in Patients With Parkinson's Disease.

Victor Spiandor Beretta1, Rodrigo Vitório1,2, Priscila Nóbrega-Sousa1, Núbia Ribeiro Conceição1, Diego Orcioli-Silva1, Marcelo Pinto Pereira1, Lilian Teresa Bucken Gobbi1.   

Abstract

BACKGROUND: Habituation of postural response to perturbations is impaired in people with Parkinson's disease (PD) due to deficits in cortico-basal pathways. Although transcranial direct current stimulation (tDCS) modulate cortico-basal networks, it remains unclear if it can benefit postural control in PD.
OBJECTIVE: To analyze the effect of different intensities of anodal tDCS on postural responses and prefrontal cortex (PFC) activity during the habituation to the external perturbation in patients with PD (n = 24).
METHODS: Anodal tDCS was applied over the primary motor cortex (M1) with 1 mA, 2 mA, and sham stimulation in 3 different sessions (~2 weeks apart) during 20 minutes immediately before the postural assessment. External perturbation (7 trials) was applied by a support base posterior translation (20 cm/s and 5 cm). Primary outcome measures included lower limb electromyography and center of pressure parameters. Measures of PFC activity are reported as exploratory outcomes. Analyses of variance (Stimulation Condition × Trial) were performed.
RESULTS: Habituation of perturbation was evidenced independent of the stimulation conditions. Both active stimulation intensities had shorter recovery time and a trend for lower cortical activity in the stimulated hemisphere when compared to sham condition. Shorter onset latency of the medial gastrocnemius as well as lower cortical activity in the nonstimulated hemisphere were only observed after 2 mA concerning the sham condition.
CONCLUSIONS: tDCS over M1 improved the postural response to external perturbation in PD, with better response observed for 2 mA compared with 1 mA. However, tDCS seems to be inefficient in modifying the habituation of perturbation.

Entities:  

Keywords:  electromyography; fNIRS; movement disorders; neurodegenerative disease; posture; tDCS

Year:  2020        PMID: 33000679     DOI: 10.1177/1545968320962513

Source DB:  PubMed          Journal:  Neurorehabil Neural Repair        ISSN: 1545-9683            Impact factor:   3.919


  5 in total

Review 1.  Systemic Review on Transcranial Electrical Stimulation Parameters and EEG/fNIRS Features for Brain Diseases.

Authors:  Dalin Yang; Yong-Il Shin; Keum-Shik Hong
Journal:  Front Neurosci       Date:  2021-03-26       Impact factor: 4.677

2.  Transcranial Direct Current Stimulation on Parkinson's Disease: Systematic Review and Meta-Analysis.

Authors:  Paloma Cristina Alves de Oliveira; Thiago Anderson Brito de Araújo; Daniel Gomes da Silva Machado; Abner Cardoso Rodrigues; Marom Bikson; Suellen Marinho Andrade; Alexandre Hideki Okano; Hougelle Simplicio; Rodrigo Pegado; Edgard Morya
Journal:  Front Neurol       Date:  2022-01-10       Impact factor: 4.003

3.  Brain Activation During Active Balancing and Its Behavioral Relevance in Younger and Older Adults: A Functional Near-Infrared Spectroscopy (fNIRS) Study.

Authors:  Nico Lehmann; Yves-Alain Kuhn; Martin Keller; Norman Aye; Fabian Herold; Bogdan Draganski; Wolfgang Taube; Marco Taubert
Journal:  Front Aging Neurosci       Date:  2022-03-25       Impact factor: 5.750

Review 4.  Therapeutic Devices for Motor Symptoms in Parkinson's Disease: Current Progress and a Systematic Review of Recent Randomized Controlled Trials.

Authors:  Joji Fujikawa; Ryoma Morigaki; Nobuaki Yamamoto; Teruo Oda; Hiroshi Nakanishi; Yuishin Izumi; Yasushi Takagi
Journal:  Front Aging Neurosci       Date:  2022-03-29       Impact factor: 5.702

Review 5.  The effects of transcranial direct current stimulation on gait in patients with Parkinson's disease: a systematic review.

Authors:  Fateme Pol; Mohammad Ali Salehinejad; Hamzeh Baharlouei; Michael A Nitsche
Journal:  Transl Neurodegener       Date:  2021-06-29       Impact factor: 8.014

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.